Differential mRNA expression and the uptake of methotrexate in primary MAEC and MLF cells: Involvement of the Abc and Slco/Oatp transporters in alveolar epithelial cell toxicity

Journal of Toxicological Sciences

Volumn 38, Issue 1, 2013, Pages 103-114

  Ohbayashi, Masayuki ^a   Yamamoto, Chie ^a   Shiozawa, Ayaka ^a   Kohyama, Noriko ^a   Kobayashi, Yasuna ^a   Yamamoto, Toshinori ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Drug transporters; MAEC; Methotrexate; MLF; Pulmonary toxicity

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; METHOTREXATE; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 4; MULTIDRUG RESISTANCE PROTEIN 5; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 2; ORGANIC ANION TRANSPORTER 3; ORGANIC ANION TRANSPORTER 4; REDUCED FOLATE CARRIER; VERLUKAST;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; LIVER TOXICITY; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROBLAST; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84873111875     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.38.103     Document Type: Article

References (29)

1. Borst, P., de Wolf, C. and van de Wetering, K. (2007): Multidrug resistance-associated proteins 3, 4, and 5. Pflugers. Arch., 453, 661-673.
2. Brcakova, E., Fuksa, L., Cermanova, J., Kolouchova, G., Hroch, M., Hirsova, P., Martinkova, J., Staud, F. and Micuda, S. (2009): Alteration of methotrexate biliary and renal elimination during extrahepatic and intrahepatic cholestasis in rats. Biol. Pharm. Bull., 32, 1978-1985.
3. Carson, C.W., Cannon, G.W., Egger, M.J., Ward, J.R. and Clegg, D.O. (1987): Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate. Semin. Arthritis Rheum., 16, 186-195.
4. Chomczynski, P. and Sacchi, N. (1987): Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
5. Chu, X.Y., Bleasby, K., Yabut, J., Cai, X., Chan, G.H., Hafey, M.J., Xu, S., Bergman, A.J., Braun, M.P., Dean, D.C. and Evers, R. (2007): Transport of the dipeptidyl peptidase-4 inhibitor sitagliptin by human organic anion transporter 3, organic anion transporting polypeptide 4C1, and multidrug resistance P-glycoprotein. J. Pharmacol. Exp. Ther., 321, 673-683.
6. Dixon, K.H., Lanpher, B.C., Chiu, J., Kelley, K. and Cowan, K.H. (1994): A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells. J. Biol. Chem., 269, 17-20.
7. Gispen, J.G., Alarcon, G.S., Johnson, J.J., Acton, R.T., Barger, B.O. and Koopman, W.J. (1987): Toxicity of methotrexate in rheumatoid arthritis. J. Rheumatol., 14, 74-79.
8. Imokawa, S., Colby, T.V., Leslie, K.O. and Helmers, R.A. (2000): Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur. Respir. J., 15, 373-381.
9. Jacobs, W.G. (2012): Optimal use of non-biologic therapy in the treatment of rheumatoid arthritis. Rheumatology, 51, iv3-iv8.
10. Klaassenn, C.D. and Aleksunes, L.M. (2010): Xenobiotic, bile acid and cholesterol transporters: function and regulation. Pharmacol. Rev., 62, 1-96.
11. Kobayashi, Y., Hirokawa, N., Ohshiro, N., Sekine, T., Sasaki, T., Tokuyama, S., Endou, H. and Yamamoto, T. (2002a): Differential gene expression of organic anion transporters in male and female rats. Biochem. Biophys. Res. Commun., 290, 482-487.
12. Kobayashi, Y., Ohshiro N., Shibusawa A., Sasaki T., Tokuyama S., Sekine T., Endou H. and Yamamoto T. (2002b): Isolation, characterization and differential gene expression of multispecific organic anion transporter 2 in mice. Mol. Pharmacol., 62, 7-14.
13. Konig, J. (2011): Uptake transporters of the human OATP family: molecular characteristics, substrates, their role in drug-drug interactions, and functional consequences of polymorphisms. Handb. Exp. Pharmacol., 201, 1-28.
14. Kremer, J.M., Galivan, J., Streckfuss, A. and Kamen, B. (1986): Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates. Arthritis Rheum., 29, 832-835.
15. Kremer, J.M., Alarcon, G.S., Weinblatt, M.E., Kaymakcian, M.V., Macaluso, M., Cannon, G.W., Palmer, W.R., Sundy, J.S., St Clair, E.W., Alexander, R.W., Smith, G.J. and Axiotis, C.A. (1997): Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review. Arthritis Rheum., 40, 1829-1837.
16. Kusuhara, H., Sekine, T., Utsunomiya-Tate, N., Tsuda, M., Kojima, R., Cha, S.H., Sugiyama, Y., Kanai, Y. and Endou, H. (1999): Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J. Biol. Chem., 274, 13675-13680.
17. Maher, J.M., Slitt, A.L., Cherrington, N.J., Cheng, X. and Klaassen, C.D. (2005): Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (Mrp) family in mice. Drug Metab. Dispos., 33, 947-955.
18. Mason, J.W. (1987): Amiodarone. N. Engl. J. Med., 316, 455-466.
19. Matsson, P., Pedersen, J.M., Norinder, U., Bergstrom, C.A. and Artursson, P. (2009): Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs. Pharm. Res., 26, 1816-1831.
20. Mikkaichi, T., Suzuki, T., Onogawa, T., Tanemoto, M., Mizutamari, H., Okada, M., Chaki, T., Masuda, S., Tokui, T., Eto, N., Abe, M., Satoh, F., Unno, M., Hishinuma, T., Inui, K., Ito, S., Goto, J. and Abe, T. (2004): Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney. Proc. Natl. Acad. Sci. USA, 101, 3569-3574.
21. Ohbayashi, M., Suzuki, M., Yashiro, Y., Fukuwaka, S., Yasuda, M., Kohyama, N., Kobayashi, Y. and Yamamoto, T. (2010): Induction of pulmonary fibrosis by methotrexate treatment in mice lung in vivo and in vitro. J. Toxicol. Sci., 35, 653-661.
22. Saito, H., Masuda, S. and Inui, K. (1996): Cloning and functional characterization of a novel rat organic anion transporter mediating basolateral uptake of methotrexate in the kidney. J. Biol. Chem., 271, 20719-20725.
23. Seki, S., Kobayashi, M., Itagaki, S., Hirano, T. and Iseki, K. (2009): Contribution of organic anion transporting polypeptide OATP2B1 to amiodarone accumulation in lung epithelial cells. Biochim. Biophys. Acta., 1788, 911-917.
24. Sekine, T., Watanabe, N., Hosoyamada, M., Kanai, Y. and Endou, H. (1997): Expression cloning and characterization of a novel multispecific organic anion transporter. J. Biol. Chem., 272, 18526-18529.
25. St. Clair, E.W Rice, J.R. and Snyderman, R. (1985): Pneumonitis complicating low-dose methotrexate therapy in rheumatoid arthritis. Arch. Intern. Med., 145, 2035-2038.
26. Visentin, M., Chang, M.H., Romero, M.F., Zhao, R. and Goldman, I.D. (2012): Substrate- and pH-specific antifolate transport mediated by organic anion-transporting polypeptide 2B1 (OATP2B1- SLCO2B1). Mol. Pharmacol., 81, 134-142.
27. Zeng, H., Chen, Z.S., Belinsky, M.G., Rea, P.A. and Kruh, G.D. (2001): Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport. Cancer Res., 61, 7225-7232.
28. Zhou, S.F. (2008): Role of multidrug resistance associated proteins in drug development. Drug Discov. Ther., 2, 305-332.
29. Zisman, D.A., McCune, W.J., Tino, G. and Lynch, J.P. 3rd. (2001): Drug-induced pneumonitis: the role of methotrexate. Sarcoidosis Vasc. Diffuse Lung Dis., 18, 243-252.